Skip to content
Homepage
Author:
Persist AI Formulations
Posted Date:
June 3, 2026
Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage “Micromill” Formulation Platform, Enabling Drug Development Decision With Milligrams of API
Persist AI Formulations
June 3, 2026
The Solubility Company and Persist AI Unveil Strategic Partnership to Enable Microgram-Level Formulation Development and Bridge the Data Gap in AI-Driven Drug Formulation
Persist AI Formulations
May 28, 2026
CyanoCapture and Persist AI Announce Strategic Collaboration to Build World’s First Robotic GMP Facility for Oral Protein and Peptide Drugs
Persist AI Formulations
February 18, 2026
